Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may...
Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may...
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply...
Compensation for research-related harm: The implications of Venter vRoche Products(Pty) Limited and Others for research ethics committees. You can contact theRoche Products(Ireland) Limited Data Protection Co-Ordinator by email at pat.lennon@roche.com. ...
RocheProductsPty.Limited,DeeWhy|RocheVitaminsAustraliaPty.Limited,FrenchForest|SyntexAustraliaLimited,NorthSydney|RocheDiagnosticsAus-traliaPty.Limited,CastleHill.Austria:RocheAustriaGmbH,Vienna|RocheDiagnosticsGmbH,Vienna.Bangladesh:RocheBangladeshLtd.,Dhaka.Belgium:N.V.RocheS.A.,Brussels|S.A.CitriqueBelgeN.V....
Media Careers Media Careers For professionals
SpeeDx tests and technology aim to enhance Roche molecular microbiology testing menu SYDNEY--(BUSINESS WIRE)--#ResistanceGuidedTherapy--SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has partnered with Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceu...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has partnered with Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics, in a non-exclusive agreement to expand global access to SpeeDx infectious disease an...
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: LysLeuThrIleGluSerThrProPheAsnValAlaGluGlyLysGlu 151015 ValLeuLeuLeuValHisAsnLeuProGlnHisLeuPheGlyTyrSer 202530 TrpTyrLysGlyGluArgValAspGlyAsnArgGlnIleIleGlyTyr 354045 ValIleGlyThrGlnGlnAlaThrProGlyProAlaTyrSerGlyArg 505560 GluIleIleTyrProAsnAlaSerLeuLeuI...